Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 15:15:784987.
doi: 10.3389/fnins.2021.784987. eCollection 2021.

The Role of Mitochondria in Optic Atrophy With Autosomal Inheritance

Elin L Strachan  1   2 , Delphi Mac White-Begg  1   3 , John Crean  1   2   4 , Alison L Reynolds  1   3 , Breandán N Kennedy  1   2 , Niamh C O'Sullivan  1   2
Affiliations
Review

The Role of Mitochondria in Optic Atrophy With Autosomal Inheritance

Elin L Strachan et al. Front Neurosci. .

Abstract

Optic atrophy (OA) with autosomal inheritance is a form of optic neuropathy characterized by the progressive and irreversible loss of vision. In some cases, this is accompanied by additional, typically neurological, extra-ocular symptoms. Underlying the loss of vision is the specific degeneration of the retinal ganglion cells (RGCs) which form the optic nerve. Whilst autosomal OA is genetically heterogenous, all currently identified causative genes appear to be associated with mitochondrial organization and function. However, it is unclear why RGCs are particularly vulnerable to mitochondrial aberration. Despite the relatively high prevalence of this disorder, there are currently no approved treatments. Combined with the lack of knowledge concerning the mechanisms through which aberrant mitochondrial function leads to RGC death, there remains a clear need for further research to identify the underlying mechanisms and develop treatments for this condition. This review summarizes the genes known to be causative of autosomal OA and the mitochondrial dysfunction caused by pathogenic mutations. Furthermore, we discuss the suitability of available in vivo models for autosomal OA with regards to both treatment development and furthering the understanding of autosomal OA pathology.

Keywords: in vivo models; mitochondria; optic atrophy; retinal ganglion cells (RGC); retinal organoids.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Unmyelinated axons within the optic nerve are associated with a greater mitochondrial load. The axons of the RGCs are unmyelinated within the retina, an adaptation which likely exists to prevent myelin from impeding light reaching the photoreceptors. Myelination initiates following the lamina cribrosa, a network of collagen fibers in the optic nerve head approximately 400 μm thick the RGC axons traverse to pass through the sclera. The unmyelinated region is associated with a higher density of mitochondria than the adjacent myelinated sections. This unique architecture of the RGCs is a possible explanation as to why the optic nerve appears so vulnerable to degeneration associated with mitochondrial dysfunction.
FIGURE 2
FIGURE 2
Mitochondrial localization and function of autosomal OA genes. Schematic demonstrating the localization and function of proteins encoded by autosomal OA-associated genes. The localization of proteins encoded by autosomal OA-associated genes within and in association with the mitochondria emphasizes the relevance of these organelles to autosomal OA. WFS1 is localized to the ER, but is enriched at MAMs. DNM1L is recruited from the cytoplasm to the OMM to facilitate mitochondrial fission. There is conflicting evidence as to whether OPA3 is localized to the IMM or OMM.
See this image and copyright information in PMC

Similar articles

  • Role of Oxidative Stress in Ocular Diseases Associated with Retinal Ganglion Cells Degeneration.
    Kang EY, Liu PK, Wen YT, Quinn PMJ, Levi SR, Wang NK, Tsai RK. Kang EY, et al. Antioxidants (Basel). 2021 Dec 5;10(12):1948. doi: 10.3390/antiox10121948. Antioxidants (Basel). 2021. PMID: 34943051 Free PMC article. Review.
  • Dominant optic atrophy.
    Lenaers G, Hamel C, Delettre C, Amati-Bonneau P, Procaccio V, Bonneau D, Reynier P, Milea D. Lenaers G, et al. Orphanet J Rare Dis. 2012 Jul 9;7:46. doi: 10.1186/1750-1172-7-46. Orphanet J Rare Dis. 2012. PMID: 22776096 Free PMC article. Review.
  • Dominant optic atrophy: Culprit mitochondria in the optic nerve.
    Lenaers G, Neutzner A, Le Dantec Y, Jüschke C, Xiao T, Decembrini S, Swirski S, Kieninger S, Agca C, Kim US, Reynier P, Yu-Wai-Man P, Neidhardt J, Wissinger B. Lenaers G, et al. Prog Retin Eye Res. 2021 Jul;83:100935. doi: 10.1016/j.preteyeres.2020.100935. Epub 2020 Dec 17. Prog Retin Eye Res. 2021. PMID: 33340656 Review.
  • New avenues for therapy in mitochondrial optic neuropathies.
    Ng WSV, Trigano M, Freeman T, Varrichio C, Kandaswamy DK, Newland B, Brancale A, Rozanowska M, Votruba M. Ng WSV, et al. Ther Adv Rare Dis. 2021 Jul 19;2:26330040211029037. doi: 10.1177/26330040211029037. eCollection 2021 Jan-Dec. Ther Adv Rare Dis. 2021. PMID: 37181108 Free PMC article. Review.
  • Wolfram syndrome: new pathophysiological insights and therapeutic strategies.
    Mishra R, Chen BS, Richa P, Yu-Wai-Man P. Mishra R, et al. Ther Adv Rare Dis. 2021 Aug 16;2:26330040211039518. doi: 10.1177/26330040211039518. eCollection 2021 Jan-Dec. Ther Adv Rare Dis. 2021. PMID: 37181110 Free PMC article. Review.
See all similar articles

Cited by

References

    1. Abrams A. J., Hufnagel R. B., Rebelo A., Zanna C., Patel N., Gonzalez M. A., et al. (2015). Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder. Nat. Genet. 47 926–932. 10.1038/ng.3354 - DOI - PMC - PubMed
    1. Ali M. S., Suda K., Kowada R., Ueoka I., Yoshida H., Yamaguchi M. (2020). Neuron-specific knockdown of solute carrier protein SLC25A46a induces locomotive defects, an abnormal neuron terminal morphology, learning disability, and shortened lifespan. IBRO Rep. 8 65–75. 10.1016/j.ibror.2020.02.001 - DOI - PMC - PubMed
    1. Almind G. J., Ek J., Rosenberg T., Eiberg H., Larsen M., LuCamp L., et al. (2012). Dominant optic atrophy in Denmark - report of 15 novel mutations in OPA1, using a strategy with a detection rate of 90. BMC Med. Genet. 13:65. 10.1186/1471-2350-13-65 - DOI - PMC - PubMed
    1. Altanbyek V., Cha S.-J., Kang G.-U., Im D. S., Lee S., Kim H.-J., et al. (2016). Imbalance of mitochondrial dynamics in Drosophila models of amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 481 259–264. 10.1016/j.bbrc.2016.10.134 - DOI - PubMed
    1. Amati-Bonneau P., Milea D., Bonneau D., Chevrollier A., Ferré M., Guillet V., et al. (2009). OPA1-associated disorders: Phenotypes and pathophysiology. Int. J. Biochem. Cell Biol. 41 1855–1865. 10.1016/j.biocel.2009.04.012 - DOI - PubMed

LinkOut - more resources